These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26540628)

  • 1. Quantification of reactive carbonyl compounds in icodextrin-based peritoneal dialysis fluids by combined UHPLC-DAD and -MS/MS detection.
    Gensberger-Reigl S; Huppert J; Pischetsrieder M
    J Pharm Biomed Anal; 2016 Jan; 118():132-138. PubMed ID: 26540628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative Profiling of Polyglucose Degradation Products in Peritoneal Dialysis Fluids.
    Gensberger S; Knabner C; Waibel R; Huppert J; Pischetsrieder M
    Anal Chem; 2015 Jun; 87(12):6103-11. PubMed ID: 25970747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: identification, quantification by HPLC/DAD/MSMS and its pathway of formation.
    Mittelmaier S; Fünfrocken M; Fenn D; Pischetsrieder M
    Anal Bioanal Chem; 2011 Feb; 399(4):1689-97. PubMed ID: 21136045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of the six major α-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC/DAD/MSMS.
    Mittelmaier S; Fünfrocken M; Fenn D; Berlich R; Pischetsrieder M
    Anal Bioanal Chem; 2011 Sep; 401(4):1183-93. PubMed ID: 21725830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
    Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
    Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC/DAD/MSMS.
    Mittelmaier S; Fünfrocken M; Fenn D; Fichert T; Pischetsrieder M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Apr; 878(11-12):877-82. PubMed ID: 20189892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of 1,2-dicarbonyl compounds, intermediates in the formation of advanced glycation end-products, during heat-sterilization of glucose-based peritoneal dialysis fluids.
    Schalkwijk CG; Posthuma N; ten Brink HJ; ter Wee PM; Teerlink T
    Perit Dial Int; 1999; 19(4):325-33. PubMed ID: 10507813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
    García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
    Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids.
    Gensberger-Reigl S; Weigel I; Stützer J; Auditore A; Nikolaus T; Pischetsrieder M
    Sci Rep; 2022 Mar; 12(1):4268. PubMed ID: 35277529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.
    Mittelmaier S; Niwa T; Pischetsrieder M
    J Ren Nutr; 2012 Jan; 22(1):181-5. PubMed ID: 22200439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid assay for icodextrin determination in plasma and dialysate.
    Wang R; Moberly JB; Martis L; Shockley TR; Mongoven JW; Patel H; Kunzler J; Hughes G; Gass J
    Adv Perit Dial; 2002; 18():91-5. PubMed ID: 12402596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids.
    Frischmann M; Spitzer J; Fünfrocken M; Mittelmaier S; Deckert M; Fichert T; Pischetsrieder M
    Biomed Chromatogr; 2009 Aug; 23(8):843-51. PubMed ID: 19353694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Degradation Products Formed during Heat Sterilization of Glucose Solutions by LC-MS/MS: Impact of Autoclaving Temperature and Duration on Degradation.
    Leitzen S; Vogel M; Steffens M; Zapf T; Müller CE; Brandl M
    Pharmaceuticals (Basel); 2021 Nov; 14(11):. PubMed ID: 34832903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
    Perit Dial Int; 2005; 25(6):583-90. PubMed ID: 16411526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to avoid glucose degradation products in peritoneal dialysis fluids.
    Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
    Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.
    Patel RP; Shastri MD; Bakkari M; Wanandy T; Jose MD
    Perit Dial Int; 2014; 34(2):212-8. PubMed ID: 24385326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of glucose degradation products in heat-sterilized glucose solutions for parenteral use by thin-layer chromatography.
    Leitzen S; Vogel M; Engels A; Zapf T; Brandl M
    PLoS One; 2021; 16(7):e0253811. PubMed ID: 34214128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
    Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
    Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
    Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
    Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.